University Hospitals Rainbow Babies & Children's Hospital
Welcome,         Profile    Billing    Logout  
 9 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Shein, Steven L
NCT05026749: Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

Recruiting
3
370
US
AZM Group, Control Group
University of Alabama at Birmingham
Respiratory Syncytial Virus Infections
07/25
07/26
GRACE-2, NCT05266001: GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS

Terminated
3
141
US
GM-CSF, Placebo
Nationwide Children's Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
12/24
12/24
TRIPS, NCT05267821: Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Recruiting
2/3
500
US
Anakinra, Placebo
Nationwide Children's Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
05/27
08/27
PICS-p, NCT04967365: Post-Intensive Care Syndrome - Pediatrics (): Longitudinal Cohort Study

Active, not recruiting
N/A
755
US
University of Pennsylvania, Seattle Children's Hospital, Boston Children's Hospital
Critical Illness, Post Intensive Care Unit Syndrome
06/25
06/25
Ross, Kristie
NCT05757102: A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Recruiting
3
292
US, RoW
FF/UMEC/VI, ELLIPTA, FF/VI
GlaxoSmithKline
Asthma
01/27
01/27
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
NCT04129931: PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Active, not recruiting
2
395
US
MCT, Breathe Better Diet (BBD), Clazakizumab, Anti-interleukin 6 monoclonal antibody, Anti-IL-6 mAb, BMS-945429, ALD518, Broncho-Vaxom, OM-85 BV VEGETAL, Imatinib Mesylate, Gleevec, Zoleta, Glivec, Ziatir, Cavosonstat, N91115, Placebo
University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI)
Asthma
12/24
12/24
NCT03617718: Project 2 Airway Potential Hydrogen (pH) in Asthma

Recruiting
1/2
74
US
Glycine Buffer
Case Western Reserve University, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), University Hospitals Cleveland Medical Center
Cystic Fibrosis, Asthma, Severe Persistent Asthma, Healthy
06/27
06/27
NCT03926741: GSNOR Phenotyping/GSNO Challenge in Severe Asthma

Completed
1
49
US
GSNO
James Reynolds, University Hospitals Cleveland Medical Center, Case Western Reserve University, National Heart, Lung, and Blood Institute (NHLBI)
Asthma, Healthy Volunteers
02/24
02/24
Logan, Laurie
NCT01606826: Severe Asthma Research Program

Active, not recruiting
N/A
1100
US
Milton S. Hershey Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Asthma
06/26
12/26
Veri, Laura
NCT04129931: PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Active, not recruiting
2
395
US
MCT, Breathe Better Diet (BBD), Clazakizumab, Anti-interleukin 6 monoclonal antibody, Anti-IL-6 mAb, BMS-945429, ALD518, Broncho-Vaxom, OM-85 BV VEGETAL, Imatinib Mesylate, Gleevec, Zoleta, Glivec, Ziatir, Cavosonstat, N91115, Placebo
University of North Carolina, Chapel Hill, National Heart, Lung, and Blood Institute (NHLBI)
Asthma
12/24
12/24

Download Options